Author

Falian He

Observed institutions: Shandong University, Sun Yat-sen University, Kunming Medical University, Chinese People's Liberation Army, Qilu Hospital of Shandong University

ORCID: 0000-0003-1807-8626

Observed ORCID: 0000-0003-1807-8626

OpenAlex ID: A5008009833

Exosomes derived from mesenchymal stem cells attenuate diabetic kidney disease by inhibiting cell apoptosis and epithelial‐to‐mesenchymal transition via miR‐424‐5p

2022 · Chen Cui, Nan Zang, et al. · The FASEB Journal · 52

Loss of ATF4 leads to functional aging-like attrition of adult hematopoietic stem cells

2021 · Yan Sun, Xiaolin Lin, et al. · Science Advances · 36

Multi-functional composite dressings with sustained release of MSC-SLP and anti-adhesion property for accelerating wound healing

2024 · Wu Duan, Haipeng Wang, et al. · Materials Today Bio · 16

Tailoring cell therapies for diabetic metabolic phenotypes: a comparative study on the efficacy of various umbilical cord-derived cell regimens

2024 · Lingshu Wang, Liming Wang, et al. · Stem Cells Translational Medicine · 1

Mesenchymal Stem Cells Ameliorate Mitochondrial Dysfunction in α - cells and Hyperglucagonemia in type 2 Diabetes via SIRT1/FoxO3a Signaling

2021 · Jia Song, Lingshu Wang, et al. · Research Square

Umbilical Cord Mesenchymal Stem Cells for the Treatment of Atherosclerosis in a Mouse Model: A Randomized Controlled Trial

2021 · Yijia Song, Gaomiyang Liu, et al. · Research Square

Comparisons of two isolation methods for exosomes from human umbilical cord mesenchymal stem cells

2017 · Mi-yang Liu-Gao, Xinghu Pan, et al. · Chin J Cell Stem Cell (Electronic Edition)

Works count: 7

Citation count: 105

H-index: 3

I10-index: 3